Skip to main content
Department of Industrial Pharmacy

Researches The department research plan participates in solving problems that face the pharmaceutical industry in the vicinity of Asyut City and others. Staff members are also supervising and teaching post-graduate students, Diploma, MSc. and Ph.D. students, and the proposed advanced and novel specializations in pharmaceutical sciences for the next 5 years plan listed below: Targeted drug delivery using Micro-/Nan particulate technologies (Polymeric particles, micro-emulsions, liposomes, etc.) Enhancing peptide and protein drug delivery via the oral and pulmonary routes. Controlled release formulation of drugs. Enhancing drug dissolution and bioavailability. Gastro-retentive technology. Transdermal drug delivery.

# Title Research Year
11 Non-coding RNA-directed therapeutics in lung cancer: Delivery technologies and clinical applications 2023
12 Exploration of the safety and solubilization, dissolution, analgesic effects of common basic excipients on the NSAID drug ketoprofen 2023
13 Silver nanoparticles coated with polymers: synthesis, characterization and loading with rousvastatin calcium 2023
14 Captopril Polyvinyl Alcohol/Sodium Alginate/Gelatin-Based Oral Dispersible Films (ODFs) with Modified Release and Advanced Oral Bioavailability for the Treatment of Pediatric Hypertension 2023
15 LIPID NANOPARTICLES TECHNOLOGY IN VACCINES; SHAPING THE FUTURE OF PROPHYLACTIC MEDICINE 2023
16 Impact of the functional coating of silver nanoparticles on their in vivo performance and biosafety 2023
17 A Novel C Fe Cu Nanocomposite Loaded with Doxorubicin Tailored for the Treatment of Hepatocellular Carcinoma 2022
18 Clinical Translations of Nanomedicines; Key, challenges and Opportunities 2022
19 Design-of-experiment approach to quantify the effect of nano-sized silica on tableting properties of microcrystalline cellulose to facilitate direct compression tableting of binary blend containing a low-dose drug 2022
20 Design and optimization of PEGylated silver nanoparticles for efficient delivery of Doxorubicin to cancer cells 2022